Company
Antabio
FIGHTING Drug Resistant Infections
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Labège, France
- Legal name
- ANTABIO
- antabio.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
We are a privately-held clinical-stage biopharmaceutical company developing novel antibacterials targeting drug-resistant pathogens that are deemed a critical priority by the WHO.
Funding snapshot
- Latest round
- Series B2023-12-12
Funding rounds
- Series B
- 2023-12-12
- Grant
- 2021-03-16
Products
- Other
- Meropenem-Pilabactam (MEM-PIL, formerly MEM-ANT3310)
Loading relationship preview